Προσφορά για την προμήθεια Pasireotide 40mg και Pasireotide 60mg “Signifor” με Διαδικασία Διαπραγμάτευσης χωρίς δημοσίευση προκήρυξης διαγωνισμού , ΔΔΧΔΠΔ.ΣΠΥΥ 1 /2026 (Ο.Α.Υ.)
can-standardContract or concession award notice – standard regime00354417-2026DIDepartment of Insolvency
Estimated value—
Deadline—
Competition00 participants
Lots11 lot
Keep momentum on this opportunity
Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.
- Save and reuse search filters
- Track opportunities as pursuits
- Get notified when new notices match
Quick actions
Keep this notice in a shortlist so you can return to it without starting a bid.
Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.
Start bid workspace
Open the bid workspace only when your team is ready to prepare a response. This does not submit a bid or contact the buyer.
Key information
Identifier
Contract type
—
Deadline
—
CPV codes
33642000 - Systemic hormonal preparations, excl. sex hormones
Status
Awarded
Notice type
can-standardContract or concession award notice – standard regime
Source
Estimated value
—
Publication date
25 May 2026, 22:00
Overview
Προμήθεια Pasireotide 40mg και Pasireotide 60mg “Signifor” με Διαδικασία Διαπραγμάτευσης χωρίς δημοσίευση προκήρυξης διαγωνισμού , ΔΔΧΔΠΔ.ΣΠΥΥ 1 /2026 (Ο.Α.Υ.)
Ο διαγωνισμός διενεργήθηκε από τη Διεύθυνση Αγορών και Προμηθειών του Υπουργείου Υγείας εκ μέρους του Οργανισμού Ασφάλισης Υγείας (Ο.Α.Υ.)
Lots1
Documentation0
The source system does not support document syncing.
Award criteria0
No procedure-level award criteria recorded.